• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测量神经递质转运体摄取活性的基于荧光的高通量检测方法的验证

Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.

作者信息

Jørgensen Susanne, Nielsen Elsebet Østergaard, Peters Dan, Dyhring Tino

机构信息

NeuroSearch A/S, Drug Discovery, 93 Pederstrupvej, Ballerup DK-2750, Denmark.

出版信息

J Neurosci Methods. 2008 Mar 30;169(1):168-76. doi: 10.1016/j.jneumeth.2007.12.004. Epub 2007 Dec 17.

DOI:10.1016/j.jneumeth.2007.12.004
PMID:18222006
Abstract

Pre-synaptic dopamine, norepinephrine and serotonin transporters (DAT, NET and SERT) terminate synaptic catecholamine transmission through reuptake of released neurotransmitter. Common approaches for studying these transporters involve radiolabeled substrates or inhibitors which, however, have several limitations. In this study we have used a novel neurotransmitter transporter uptake assay kit. The assay employs a fluorescent substrate that mimics the biogenic amine neurotransmitters and is taken up by the cell through the specific transporters, resulting in increased fluorescence intensity. In order to validate the assay, a variety of reference and proprietary neurotransmitter transporter ligands from a number of chemical and pharmacological classes were tested. The ability of these compounds to inhibit the selective transporter-mediated uptake demonstrated a similar rank order of potency and IC(50) values close to those obtained in radiolabeled neurotransmitter uptake assays. The described assay enables monitoring of dynamic transport activity of DAT, NET and SERT and is amenable for high-throughput screening and compound characterization.

摘要

突触前多巴胺、去甲肾上腺素和5-羟色胺转运体(DAT、NET和SERT)通过再摄取释放的神经递质来终止突触儿茶酚胺传递。研究这些转运体的常用方法涉及放射性标记底物或抑制剂,然而,这些方法存在若干局限性。在本研究中,我们使用了一种新型神经递质转运体摄取检测试剂盒。该检测采用一种荧光底物,它模拟生物胺神经递质,并通过特定转运体被细胞摄取,导致荧光强度增加。为了验证该检测方法,测试了来自多个化学和药理学类别的多种参考和专利神经递质转运体配体。这些化合物抑制选择性转运体介导摄取的能力显示出类似的效价顺序,且IC(50)值接近在放射性标记神经递质摄取检测中获得的值。所描述的检测方法能够监测DAT、NET和SERT的动态转运活性,适用于高通量筛选和化合物表征。

相似文献

1
Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.用于测量神经递质转运体摄取活性的基于荧光的高通量检测方法的验证
J Neurosci Methods. 2008 Mar 30;169(1):168-76. doi: 10.1016/j.jneumeth.2007.12.004. Epub 2007 Dec 17.
2
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
J Neurosci Methods. 2005 Apr 15;143(1):3-25. doi: 10.1016/j.jneumeth.2004.09.028. Epub 2004 Nov 28.
3
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.三取代不对称吡喃衍生物(2S,4R,5R)-2-二苯甲基-5-苄基氨基-四氢吡喃-4-醇及其相应的二取代(3S,6S)吡喃衍生物的进一步结构探索:一种与多巴胺、5-羟色胺和去甲肾上腺素转运体高亲和力相互作用的拟药效团模型。
J Med Chem. 2006 Jul 13;49(14):4239-47. doi: 10.1021/jm0601699.
4
Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.青风藤提取物激活多巴胺/去甲肾上腺素转运体并抑制5-羟色胺转运体。
Exp Biol Med (Maywood). 2009 Aug;234(8):976-85. doi: 10.3181/0903-RM-92. Epub 2009 Jun 2.
5
Pharmacological characterization of a fluorescent uptake assay for the noradrenaline transporter.
J Biomol Screen. 2007 Apr;12(3):378-84. doi: 10.1177/1087057107299524. Epub 2007 Mar 22.
6
Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.血吸虫中的神经递质转运体:结构、功能及药物研发前景
Parasitol Int. 2013 Dec;62(6):629-38. doi: 10.1016/j.parint.2013.06.003. Epub 2013 Jun 22.
7
Targeted screening for biogenic amine transporters: potential applications for natural products.
Life Sci. 2005 Dec 22;78(5):512-8. doi: 10.1016/j.lfs.2005.09.001. Epub 2005 Oct 3.
8
Tegaserod inhibits the serotonin transporter SERT.替加色罗抑制5-羟色胺转运体SERT。
Digestion. 2007;75(2-3):90-5. doi: 10.1159/000102962. Epub 2007 May 18.
9
Ancestry of neuronal monoamine transporters in the Metazoa.后生动物中神经元单胺转运体的起源。
J Exp Biol. 2006 Dec;209(Pt 24):4858-68. doi: 10.1242/jeb.02607.
10
Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.木瓜提取物对多巴胺转运体的抑制作用及抗帕金森病效应
Pharmacol Biochem Behav. 2008 Sep;90(3):363-71. doi: 10.1016/j.pbb.2008.03.014. Epub 2008 Mar 30.

引用本文的文献

1
Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation.通过基于WHALES描述符的虚拟筛选和生物活性评估将药物用于人类多巴胺转运体
J Pharm Anal. 2025 Aug;15(8):101368. doi: 10.1016/j.jpha.2025.101368. Epub 2025 Jun 14.
2
Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter.烟草中存在的单胺氧化酶抑制剂通过多巴胺转运体调节多巴胺平衡。
ACS Chem Neurosci. 2025 Mar 19;16(6):1117-1131. doi: 10.1021/acschemneuro.4c00789. Epub 2025 Mar 4.
3
Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice.
在小鼠中,氯氮平部分通过抑制OCT1介导的肝脏5-羟色胺摄取从而增加血浆5-羟色胺水平,损害葡萄糖刺激的胰岛素分泌。
Acta Pharmacol Sin. 2025 Mar;46(3):687-701. doi: 10.1038/s41401-024-01401-w. Epub 2024 Oct 29.
4
Preliminary Investigation Into the Antidepressant Effects of a Novel Curcumin Analogue (CACN136) In Vitro and In Vivo.新型姜黄素类似物(CACN136)体内外抗抑郁作用的初步研究
Mol Neurobiol. 2025 Feb;62(2):2124-2147. doi: 10.1007/s12035-024-04363-6. Epub 2024 Jul 30.
5
Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters.选择性单胺再摄取抑制剂对多巴胺转运体联合治疗的影响。
Biomedicines. 2023 Oct 20;11(10):2846. doi: 10.3390/biomedicines11102846.
6
The serotonin transporter sustains human brown adipose tissue thermogenesis.血清素转运体维持人类棕色脂肪组织的产热。
Nat Metab. 2023 Aug;5(8):1319-1336. doi: 10.1038/s42255-023-00839-2. Epub 2023 Aug 3.
7
Molecular docking and biochemical validation of (-)-syringaresinol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside binding to an allosteric site in monoamine transporters.(-)-紫丁香树脂醇-4-O-β-D-芹菜呋喃糖基-(1→2)-β-D-吡喃葡萄糖苷与单胺转运体变构位点结合的分子对接及生化验证
Front Pharmacol. 2022 Oct 28;13:1018473. doi: 10.3389/fphar.2022.1018473. eCollection 2022.
8
Determining Ligand and Ion-Induced Conformational Changes in Serotonin Transporter with Its Fluorescent Substrates.测定荧光底物与 5-羟色胺转运体相互作用诱导的构象变化。
Int J Mol Sci. 2022 Sep 18;23(18):10919. doi: 10.3390/ijms231810919.
9
Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.稳定表达人多巴胺转运体的 N27 细胞作为多巴胺细胞转运和代谢的体外模型。
Toxicol In Vitro. 2021 Oct;76:105210. doi: 10.1016/j.tiv.2021.105210. Epub 2021 Jul 5.
10
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.无标记高通量筛选测定法,用于鉴定去甲肾上腺素转运体(NET/SLC6A2)抑制剂。
Sci Rep. 2021 Jun 10;11(1):12290. doi: 10.1038/s41598-021-91700-7.